Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B7206 IBMX1 CitationSummary: Phosphodiesterase inhibitor
-
B6988 BRL 50481Target: Phosphodiesterases (PDEs)Summary: PDE7 inhibitor,potent and selective
-
B7162 CP 80633Summary: PDE4 inhibitor
-
B7257 MesopramSummary: PDE4 inhibitor, orally active
-
B7539 CDP 840 hydrochlorideSummary: PDE4 inhibitor,potent and selective
-
B7599 Gisadenafil besylateSummary: PDE5 inhibitor
-
B7673 BC 11-38Summary: Selective PDE11 inhibitor
-
B6301 MY-5445Summary: PDE5 inhibitor
-
B6304 Etazolate hydrochloride2 CitationTarget: Phosphodiesterases (PDEs)Summary: PDE-4 inhibitor and selective GABA-A receptor modulator
-
B6500 Cilostamide1 CitationSummary: type III phosphodiesterase (PDE3) inhibitor